Orteronel

• Target :

  Cytochromes P450

• Related Pathways :

  Metabolism

• Bioactivity :

  Orteronel ((S) -Orteronel) (TAK-700) was selected as a candidate for clinical evaluation. orteronel (TAK-700) is currently in phase III clinical trials for the treatment of castration-resistant prostate cancer.

• Smiles :

  CNC(=O)c1ccc2cc(ccc2c1)[C@@]1(O)CCn2cncc12

• Molecular Formula :

  C18H17N3O2

• Molecular Weight :

  307.35

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  566939-85-3